Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811700) titled 'Effect of LSD on Lipid Profiles Within 1 Year Postoperatively in Cirrhosis Patients With Portal Hypertension Bleeding' on Sept. 3.
Study Type: Observational
Primary Sponsor: Northern Jiangsu People's Hospital
Condition:
Lipid Profiles
Cirrhosis, Liver
Portal Hypertension
Splenectomy
Status
Recruitment Status: Not recruiting
Date of First Enrollment: May 1, 2022
Target Sample Size: 150
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07811700
Published by HT Digital Content Services with permission from Health Daily Digest....